Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval
Sean Khozin, Kenneth R. Carson, Jizu Zhi, Melisa Tucker, Shannon E. Lee, David E. Light, Melissa D. Curtis, Marta Bralic, Irene Kaganman, Anala Gossai, Philip Hofmeister, Aracelis Z. Torres, Rebecca A. Miksad, Gideon Michael Blumenthal, Richard Pazdur, Amy P. Abernethy
Dive into the research topics of 'Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval'. Together they form a unique fingerprint.